Author: Javier Fernandez-Diaz

05 Jun

Posted at 06:52h in Press, Sin categoría

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" padding_bottom="120"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text]54 patients with advanced solid tumours have participated in the Phase I/IIa clinical study with 2OHOA, half of them with malignant glioma. Primary objective has been achieved, with the definition or the MTD,...

12 Dec

Posted at 12:38h in Press, Sin categoría

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" padding_bottom="120"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text]Palma de Mallorca (Spain), December 12th 2016 –   The postdoctoral researcher Catalina Ana Rosselló Castillo has been awarded a Felip Bauçà fellowship at the CAIB (Comunitat Autònoma de les Illes Balears) Postdoctoral call from the...

01 Aug

Posted at 12:43h in Press, Sin categoría

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" padding_bottom="120"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text]Laminar Pharma announces the closure of patient recruitment in its first clinical study with 2OHOA (MIN-001-1203), a Phase I/IIa open label, non-randomized, safety, pharmacokinetics, pharmacodynamics and preliminary efficacy study of 2OHOA in adult...

23 Nov

Posted at 12:53h in Press, Sin categoría

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" padding_bottom="120"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text]Palma de Mallorca (Spain), November 23rd 2015 –   Laminar Pharma announced today that in the Dose Escalation TC held this morning with all the Clinical Investigators and the Medical Monitor of the MIN-001-1203 study...

29 May

Posted at 13:27h in Press, Sin categoría

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" padding_bottom="120"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text]Palma de Mallorca, May 30th 2015 –   Updated results of the ongoing Phase I/IIA clinical trial with 2OHOA in patients with advanced solid tumours, including malignant glioma (MIN-001-1203), were presented today in a poster discussion session at...

07 Apr

Posted at 13:31h in Press, Sin categoría

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" padding_bottom="120"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text]Palma de Mallorca, April 07, 2015 –   Laminar Pharma announced today that a key patent for the company, owned by the University of the Balearic Islands (UIB) and licensed in exclusive to Laminar Pharma, has...

04 Nov

Posted at 13:33h in Press, Sin categoría

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" padding_bottom="120"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text]Palma de Mallorca, November 04th, 2014 –   Laminar Pharma presented today at BIO-Europe 2014, the leading biotechnological event in Europe, held in Frankfurt (Germany) 3-5 November, the main highlights of its Phase I/IIA clinical trial with 2OHOA...

30 Oct

Posted at 13:35h in Press, Sin categoría

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" padding_bottom="120"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text]“Junior Lab” is a pioneering project launched by the Balearic Islands Biotechnology and Biomedical Cluster (BIOIB) in collaboration with Laminar Pharma and several secondary and high school centers in the Mallorca.   The objective of...

25 Aug

Posted at 13:49h in Press, Sin categoría

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" padding_bottom="120"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text]Her Majesty the Queen Sofia of Spain has made today a private visit to the Laboratory of Molecular and Cellular Biomedicine of the University of the Balearic Islands. The research group, led by...

16 Jun

Posted at 13:50h in Press, Sin categoría

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index="" padding_bottom="120"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text]Laminar Pharma Scientific Advisory Board (SAB) has held a meeting today in Madrid were a group of leading scientist had discussed the molecular basis and mechanism of action of the novel MLT-based LP226A1,...